Investigation into conolidine has resulted in discovery of an opioid receptor in the human body named ACKR3/CXCR7. ACKR3 seems to be essentially the most desired target for conolidine, which also disregards one other four classical opioid receptors(3). There's interest in utilizing conolidine for a pain-reliever determined by evidence from https://haimb319ybc0.webdesign96.com/profile